Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia.
Michael J VinikoorEdford SinkalaAnnie KanungaMutinta MuchimbaArianna ZanoliniMichael S SaagJesse Jake PryBright NsokoloTina ChisengaPaul KellyPublished in: PloS one (2020)
Approximately 1 in 6 HBV monoinfected adults in the general population in Zambia may be AVT-eligible. Men should be a major focus of hepatitis B diagnosis and treatment. Further development and evaluation of HBV treatment criteria for resource-limited settings is needed. In settings with overlapping HIV and HBV epidemics, scale-up of ART has contributed towards hepatitis B elimination.